Developing new medications for treating alcohol use disorder
NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder
This study is looking for better medications to help people with alcohol use disorder, and if you join, you might get to try new treatments that could improve your recovery.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10506122 on NIH RePORTER |
What this research studies
This research focuses on finding new and more effective medications to treat alcohol use disorder, as current FDA-approved options are limited and not effective for everyone. The project involves conducting phase II clinical trials at various research sites to evaluate the safety and efficacy of these new pharmacotherapies. Patients participating in these trials may receive novel treatments that are not yet available on the market, potentially improving their chances of recovery. The research aims to identify new molecular targets that could lead to better treatment options for individuals struggling with alcohol-related issues.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with alcohol use disorder who are seeking treatment options.
Not a fit: Patients who do not have alcohol use disorder or those who are not seeking treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective medications for individuals with alcohol use disorder, improving treatment outcomes.
How similar studies have performed: Previous research has shown promise in developing new pharmacotherapies for alcohol use disorder, but this specific approach is part of an ongoing effort to expand treatment options.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Tiouririne, Nassima — University of Virginia
- Study coordinator: Tiouririne, Nassima
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.